More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases
Doe v. Favor, Inc., 3:23-00059 (N.D. Cal.).
Data Breach and Privacy, Data Privacy
Lowey Dannenberg represents a class of Favor (formerly Pill Club) website and app users alleging their personal data, including prescription information relating to birth control and Plan B, were unlawfully […]
Doe. v. Good Rx Holdings, Inc., No. 3:23-cv-00501-AMO (N.D. Cal.)
Data Privacy
Lowey serves as interim co-lead class counsel on behalf of Plaintiffs and Class members alleging that advertisers Google, Meta, and Criteo unlawfully intercepted GoodRx users’ medical information, including prescription information, as a result of GoodRx’s incorporation of its co-defendants’ tracking […]
OneMain Holdings
Securities
By Andrea Farah
Lowey Dannenberg, P.C. is Investigating OneMain Holdings (NYSE: OMF) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm Lowey Dannenberg P.C., a preeminent law […]
News
Lowey Dannenberg Appointed Co-Lead Counsel in Nelnet Breach Litigation
On January 30, 2023, Judge Cheryl R. Zwart appointed Lowey Dannenberg, P.C. as one of two Co-Lead Interim Class Counsel representing a proposed class of consumer plaintiffs in In re: Data Security Cases Against Nelnet Servicing, LLC, No. 4:22-cv-3191 (D. Neb.). The…
Blog
Pharma Industry Takes Advantage of COVID Epidemic to Mislead Investors
Recently, several major players in the pharmaceutical industry have faced severe shareholder scrutiny for misleading the public regarding their roles in the production of COVID-19 vaccines. The company to most recently fall in the limelight is Emergent Biosolutions (“Emergent”). Emergent had...